On June 11, 2021, the opening ceremony of Oceanpine Capital invested company——Immune Onc (Hangzhou) Co., Ltd. was successfully held in Hangzhou Biotechnology Valley Lingkong Dongchuang Innovation Center...

Oceanpine Capital has closed a new RMB-denominated fund at 2 billion yuan ($313.4 million) as it seeks to up the ante on deep technology investments...

Oceanpine Capital investee company——Xforceplus Information Technology has raked in $200 million in its Series C+ and C++ rounds of financing. This brings the total corpus raised by the IT company in its Series C round to about $200 million...

On May 20, 2021, Oceanpine Capital’s invested company, TinyChip announced the completion of tens of millions of RMB in Series A financing. This round of financing was led by Oceanpine Capital...

on April 18th ,The Oceanpine Capital Investment Salon —— "The Current Status and Development of the Pharmaceutical Industry" was successfully held in Beijing...

Clinical stage drug discovery and development firm Hepagene Therapeutics Inc. on Tuesday said it has garnered a total of $40 million in its Series B1 round led by ByteDance-backer Loyal Valley Capital. Oceanpine Capital...

On April 23, Oceanpine Capital's first salon of this year—— Digital Industry and New Retail Strategy Transformation was successfully held in China Century Building...

On April 22, the investee company of Oceanpine Capital —— Horizon Robotics signed a strategic cooperation agreement with WILLSEMI and announced that it had received strategic investment from Weihao Chuangxin...

Apr. 21, 2021 -- EdiGene, Inc. ("Company", or "EdiGene"), today announced the successful completion of an RMB 400 million (approximately USD 62 million) Series B Plus financing...

Technoderma is a leader in the research and development of innovative drugs for skin indications. The success of this round of financing provides a strong support to the company to rapidly advance the preclinical research and IND filing of its drug R&D pi